Influence of insulin resistance on adiponectin receptor expression in breast cancer

Maturitas

Volumn 63, Issue 3, 2009, Pages 253-256

  Pfeiler, Georg ^a,b   Treeck, Oliver ^a   Wenzel, Gitte ^a   Goerse, Regina ^a   Hartmann, A ^c   Schmitz, Gerd ^a   Ortmann, Olaf ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adiponectin; AdipoR1; AdipoR2; Breast cancer; Insulin receptor; Insulin resistance

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; C PEPTIDE; GLUCOSE; INSULIN; INSULIN RECEPTOR; RNA; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C RECEPTOR;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER INVASION; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FROZEN SECTION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LYMPH NODE METASTASIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGE FACTORS; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN RESISTANCE; LYMPHATIC METASTASIS; OBESITY; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; RECEPTORS, ADIPONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 67649494283     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.04.006     Document Type: Article

References (25)

1. Renehan A.G., Tyson M., Egger M., Heller R.F., and Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 37 (2008) 569-578
2. McTiernan A., Rajan K.B., Tworoger S.S., et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21 (2003) 1961-1966
3. Lorincz A.M., and Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 13 (2006) 279-292
4. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
5. Abbasi F., Chu J.W., Lamendola C., et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53 (2004) 585-590
6. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
7. Miyoshi Y., Funahashi T., Kihara S., et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9 (2003) 5699-5704
8. Mantzoros C., Petridou E., Dessypris N., et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89 (2004) 1102-1107
9. Treeck O., Lattrich C., Juhasz-Boess I., Buchholz S., Pfeiler G., and Ortmann O. Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br J Cancer 99 (2008) 1246-1250
10. Arditi J.D., Venihaki M., Karalis K.P., and Chrousos G.P. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 39 (2007) 9-13
11. Pfeiler G.H., Buechler C., Neumeier M., et al. Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol. Oncol Rep 19 (2008) 787-793
12. Körner A., Pazaitou-Panayiotou K., Kelesidis T., et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab 92 (2007) 1041-1048
13. Chen D.C., Chung Y.F., Yeh Y.T., et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237 (2006) 109-114
14. Tworoger S.S., Eliassen A.H., Kelesidis T., et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92 (2007) 1510-1516
15. Kang J.H., Lee Y.Y., Yu B.Y., et al. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 28 (2005) 1263-1269
16. Ståhlberg A., Åman P., Ridell B., Mostad P., and Kubista M. A quantitative real-time PCR method for detection of B-lymphocyte monoclonality by comparison of kappa and lambda immunoglobulin light chain expression. Clin Chem 49 (2003) 51-59
17. (- delta delta Ct) method. Methods 25 (2001) 402-408
18. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
19. Mulligan A.M., O'malley F.P., Ennis M., and Fantus I.G. Goodwin PJ Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res Treat 106 (2007) 39-47
20. Surmacz E., and Bartucci M. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. J Exp Clin Cancer Res 23 (2004) 385-394
21. Takahata C., Miyoshi Y., Irahara N., Taguchi T., Tamaki Y., and Noguchi S. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett 250 (2007) 229-236
22. Tsuchida A., Yamauchi T., Ito Y., et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279 (2004) 30817-30822
23. Yamauchi T., Nio Y., Maki T., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13 (2007) 332-339
24. Dieudonne M.N., Bussiere M., Dos Santos E., Leneveu M.C., Giudicelli Y., and Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 34 (2006) 271-279
25. Pfeiler G., Treeck O., Wenzel G., Goerse R., Hartmann A., Schmitz G., and Ortmann O. Correlation of body mass index and menopausal status with the intratumoral estrogen system in invasive breast cancer. Gynecol Endocrinol 25 (2009) 183-187